Clinical trial
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III…
NCT00452920 · University of Miami, Other · Withdrawn
Key facts
| NCT number | NCT00452920 |
|---|---|
| Title | Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer |
| Official title | A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026) |
| Lead sponsor | University of Miami, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Radiation |
| Interventions | docetaxel, cesium Cs 137, radiation therapy |
| Enrollment | 0 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Mar 28, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: